Anna Porwit

<i>TP53</i> Mutations in Low-Risk Myelodysplastic Syndromes With del(5q) Predict Disease Progression

Martin Jädersten, Leonie Saft, Alexander Smith et al. · Journal of Clinical Oncology · 2011 · 460 citations · Full text

Medicine, Hematology, Oncology +17

Mixed-phenotype acute leukemia: clinical and laboratory features and outcome in 100 patients defined according to the WHO 2008 classification

Estella Matutes, Winfried F. Pickl, Mars van’t Veer et al. · Blood · 2011 · 320 citations · Full text

Medicine, Hematology, Oncology +16

ICSH guidelines for the standardization of bone marrow specimens and reports

Sang‐Hee Lee, Wendy N. Erber, Anna Porwit et al. · International Journal of Laboratory Hematology · 2008 · 313 citations · Full text

Medicine, Hematology, Pathology +13

Erythropoietin and Granulocyte-Colony Stimulating Factor Treatment Associated With Improved Survival in Myelodysplastic Syndrome

Martin Jädersten, Luca Malcovati, Ingunn Dybedal et al. · Journal of Clinical Oncology · 2008 · 297 citations · Full text

Medicine, Hematology, Chemotherapy +13

Standardization of flow cytometry in myelodysplastic syndromes: a report from an international consortium and the European LeukemiaNet Working Group

Theresia M. Westers, Robin Ireland, Wolfgang Kern et al. · Leukemia · 2012 · 244 citations · Full text

Medicine, Hematology, Oncology +17